Leyla Ersoy

Leyla Ersoy

Auto-generated profile, based on publicly available information

Leyla Ersoy

Faculty of Medicine, Medical Microbiology, Mersin University, Mersin, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
DÖDidem Özgür
Didem Özgür
LELeyla Ersoy
Leyla Ersoy
MÜMahmut Ülger
Mahmut Ülger
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
GAGonul Aslan
Gonul Aslan
Tuberculosis (TB) is caused by Mycobacterium tuberculosis, still one of the most common life-threatening infectious diseases worldwide. Although drug resistance in M.tuberculosis is mainly due to spontaneous chromosomal mutations in genes encoding drug target or drug activating enzymes, the resistance cannot be explained only by these mutations. Low permeability of the cell wall, drug inactivating enzymes and especially efflux pumps (EPs) are other mechanisms of drug resistance in mycobacteria. Efflux pump inhibitors (EPIs) binding to M.tuberculosis EPs were shown to inhibit efflux of anti-TB drugs, to enhance M.tuberculosis killing, to reduce drug resistance and to produce synergistic effects with first line anti-TB drugs. In this study, we aimed to determine the minimum inhibitory concentration (MIC) of first-line anti-TB drugs in the presence of verapamil (VER) and the expression of 21 putative EP genes belonged to the ATP-binding cassette (ABC), major facilitator superfamily (MFS) and resistance-nodulation-division (RND) families which might have caused the resistance in nine M.tuberculosis complex clinical isolates resistant to all of the first line anti-TB drugs. MIC values of the isolates were determined in 96-well U-bottom plates by the resazurin microtiter test (REMA) method based on the color change principle. According to the determined MIC values of each isolate, freshly grown cultures in Middlebrook 7H9 broth were exposed to first-line anti-TB drugs and MIC of first-line anti-TB drugs in the presence of VER (½ MIC) at 37°C for 48 hours for RNA extraction. The non-drug exposed cultures were used as control. Total RNA was extracted using the RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) and then treated with DNase I (Thermo Fischer Scientific Inc., Waltham, MA). Complementary DNA (cDNA) from the extracted RNAs was synthesized with the "First strand cDNA synthesis kit" (Thermo Fischer Scientific Inc., Waltham, MA) using oligo primers. The expression levels of efflux pump genes by quantitative realtime polymerase chain reaction (qRt-PCR) were performed using the QuantiTect SYBR Green Rt-PCR Kit (Qiagen, Germany). The housekeeping sigma factor gene sigA (Rv2703) was used as internal control in qRt‑PCR assays. Relative quantification of the clinical isolates was determined by the 2-∆∆Ct method by comparing the expression levels of efflux genes in cultures exposed to primary anti-TB drugs and VER with those of non-drug exposed cultures. MIC values of nine isolates by REMA method was determined between 32-512 μg/mL, 1-128 μg/mL, 2-32 μg/mL, 4-16 μg/mL and 15.62-250 μg/mL for streptomycin (SM), isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and VER, respectively. In the presence of ½ MIC VER, it was determined that the MIC of SM decreased 2-32 fold in eight isolates, the MIC of INH decreased by 2-8 fold in nine isolates, the MIC of RIF decreased by 2-16 fold in eight isolates, and the MIC of EMB decreased 2-4 fold in only five isolates. There was an increase in the expression of Rv1273c, Rv1456c, Rv1457 and Rv1819 efflux pump genes from the ABC family, Rv1634 and Rv0842 from the MFS family and Rv3823 efflux from the RND family in isolates exposed to ½ MIC of first-line anti-TB drugs stress. Rv1456c and Rv1819 were found to be associated with SM resistance, Rv1273c with EMB resistance, Rv1457, Rv0842 and Rv3823 with both RIF and EMB resistance, and Rv1634 with INH, RIF and EMB resistance. It was determined that there was a decrease in the expression levels of eight efflux pump genes from the ABC family (Rv1456c, Rv1457c, Rv1458c, Rv0194, Rv1272c, Rv1686c, Rv1687c, Rv1819c), six from MFS family (Rv0842, Rv0849, Rv1634, Rv2265, Rv2456c, Rv0876c) and two from RND family (Rv0507, Rv0676c) in isolates exposed to MIC of first-line anti-TB drugs in the presence of VER (½ MIC). Further studies with clinical isolates are needed to investigate the EPIs that can be used in alternative therapy and to determine the contribution of EPs to the development of resistance due to the increasing TB resistance.

19 July 2023 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
HKHamide Kaya
Hamide Kaya
LELeyla Ersoy
Leyla Ersoy
MÜMahmut Ülger
Mahmut Ülger
TBTaylan Bozok
Taylan Bozok
GAGonul Aslan
Gonul Aslan

21 January 2022 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
LELeyla Ersoy
Leyla Ersoy
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
HGHarun Gülbudak
Harun Gülbudak
NYNurbanu Yaşar
Nurbanu Yaşar
GYGulcin Yapici
Gulcin Yapici
GAGonul Aslan
Gonul Aslan
The impact of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome 2 (SARS-CoV-2) still continues. The duration of the immune response in individuals recovering from COVID-19 and its protection against future SARS-CoV-2 infection are not fully understood. This study aimed to longitudinally evaluate anti-SARS-CoV-2 seroconversion status in healthcare workers with positive SARS-CoV-2 Real-time reverse transcription polymerase chain reaction (rRT-PCR), test in Mersin University Hospital. A total of 68 healthcare workers with positive SARS-CoV-2 rRT-PCR test between 19 April and 27 November 2020 were included in the study. Blood samples were collected from healthcare workers for SARS-CoV-2 antibody testing in the 1st, 3rd and 5th months following PCR positivity. Healthcare workers were classified as symptomatic, asymptomatic and reinfected according to their clinical findings, and rRT-PCR cycle thresholds (Ct) were recorded. Elecsys Anti-SARS-CoV-2 (Roche Diagnostics, Germany) kit was used for antibody testing. Of the 68 healthcare workers; 46 were classified as symptomatic, 15 as asymptomatic, and seven as reinfected. Twenty-seven (39.7%) of the healthcare workers were male and 41 (60.3%) were female, and the mean age was 36.4 ± 9.04. Seroconversion was detected in 45 (66.2%) of 68 healthcare workers in the study, and only one person had sero-negative result at the end of the 5th month. While seroconversion was detected in 78.3% (n= 36/46) of symptomatic healthcare workers, it was observed in 26.7% (n= 4/15) of the asymptomatic healthcare workers. Seroconversion was detected in only one of the seven reinfected healthcare workers after primary infection. After reinfection, seroconversion was observed in five of seven reinfected healthcare workers. Antibody response was not detected in two of them after both infections. According to the rRT-PCR Ct values; the median of Ct value was found significantly lower in healthcare workers with seroconversion (23.26, IQR= 18.45-27.30), than the ones without seroconversion (36.20, IQR= 33.09-37.56) (p< 0.001). In those who had reinfection, the mean Ct value (31.77 ± 6.62) detected during the primary infection period was statistically higher than the Ct value (22.44 ± 5.54) detected during reinfection (p= 0.008). The most frequently recorded symptoms in healthcare workers were myalgia (57.3%), fatigue (51.5%), headache (51.5%) followed by sore throat (36.7%), fever (33.8%), cough (27.9%), diarrhea (23.5%) and dyspnea (16.2%). In addition, fever (52%) and fatigue (80.6%) were found to be significantly higher in seroconversion-positive healthcare workers than in those without seroconversion (p= 0.028; p= 0.005, respectively). As a result, a higher rate of antibody response was detected in healthcare workers who had symptomatic infection than those who were asymptomatic. It has been observed that patients with asymptomatic primary infection and without antibody response were more susceptible to reinfection. In addition, it was observed that the probability of immune response increased when the viral load increased (Ct value decreased) in symptomatic infections. Although these findings provide important information about the short-term seroconversion status of healthcare personnel; longer-term and larger-scale studies are needed to evaluate the long-term effectiveness of seroconversion and to better understand the effectiveness of the immune response developed after SARS-CoV-2 vaccine administrations.

15 January 2025 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
LELeyla Ersoy
Leyla Ersoy
SUSeda Tezcan Ulger
Seda Tezcan Ulger
AYAyca Cordan Yazici
Ayca Cordan Yazici
GAGonul Aslan
Gonul Aslan
Background: Human papillomaviruses (HPVs) are members of the Papillomaviridae family, characterized by circular, double-stranded DNA. They exhibit strict tropism, infecting either mucosa or skin. The role of HPV in the etiology of psoriasis remains unclear. Objectives: The aim of this study was to determine the presence of alpha human papillomavirus in the skin scrapings of patients with psoriasis and its genotype distributions. Methods: The study employed a cross-sectional design and included 53 psoriasis patients and 47 healthy controls from December 2020 to May 2021. After DNA isolation from skin scrapings, the L1 gene region of HPV was amplified using MY09/11 and GP5 +/6 + consensus primer sequences. The HPV genotypes were determined through direct DNA sequence analysis of polymerase chain reaction (PCR) products. Results: HPV DNA was detected in 34% of psoriasis patients and 29.8% of healthy individuals. Among the patients, HPV18 was found in 11.1%, HPV31 in 38.9%, and HPV81 in 50%. In the healthy individuals, HPV31 was found in 7.1% and HPV81 in 92.9%. HPV DNA was detected in 31.8% of patients who received psoralen UV-A (PUVA) treatment and 35.5% of those who did not. High-risk (HR) HPV18 was identified in two patients (28.6%) within the group treated with PUVA. Conclusions: There is a potential risk for psoriasis patients who receive lifelong immunosuppressive treatment in the case of persistent infections with the HR oncogenic types (HPV18 and HPV31) of alpha HPVs identified in this study. The high prevalence of low-risk HPV81 in healthy individuals suggests that alpha HPVs might occur as members of the normal skin flora without causing cutaneous lesions in healthy skin.

21 December 2021 in Turkish Journal of Immunology
Verified
Journal Article
Closed access
LELeyla Ersoy
Leyla Ersoy
AÖAhmet Ata Özçimen
Ahmet Ata Özçimen
MÜMahmut Ülger
Mahmut Ülger
MÇMukadder Çalıkoğlu
Mukadder Çalıkoğlu
GAGonul Aslan
Gonul Aslan

31 December 2021 in International Dental Research
Verified
Journal Article
Open access
PDF file
BKBertan Kesim
Bertan Kesim
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
HCHamza Cudal
Hamza Cudal
GAGonul Aslan
Gonul Aslan
LELeyla Ersoy
Leyla Ersoy
MKMustafa Öner Küçük
Mustafa Öner Küçük
Aim: The objective of this study was to evaluate the prevalence of Enterococcus faecalis in samples of oral rinse and tongue dorsum of endodontic patients with secondary/persistent infections (EPSI) using the PCR method. Methodology: Oral rinse samples (ORS) and tongue swab samples (TSS) of 22 patients (EPSI group) and 32 healthy individuals (control group) were collected. DNA isolation from the TSS and ORS samples was performed using the modified classical phenol-chloroform and chloroform method. To detect E. faecalis strains directly from the TSS and ORS samples, the 310 base pair (bp) segment of the 16S rDNA of the E. faecalis genome was amplified by PCR using specific primers. The prevalence of E. faecalis was compared between healthy and sick individuals using the Chi-square test, significance was set at p<0.05. Results: In the ORS samples, there was a significant difference between the healthy individuals (n = 11, 34%) and the EPSI group (n = 15, 68%) in terms of the presence of E. faecalis (p = 0.026). In the TSS, the presence of E. faecalis was also investigated, and a significant difference was found between healthy individuals (n = 3, 9%) and the EPSI group (n = 11, 50%) (p = 0.001). In the EPSI group, no statistically significant difference was present in the prevalence rate of E. faecalis between the samples of ORS (68%) and TSS (50%) (p = 0.358). Conclusion: The prevalence of E. faecalis was found to be statistically significantly higher in multi-site oral samples of a population with secondary endodontic infection than healthy individuals. How to cite this article: Kesim B, Tezcan Ülger S, Cudal H, Aslan G, Ersoy L, Aslan T, Küçük MÖ. Molecular detection of E. faecalis in oral samples of a population associated with secondary endodontic infection. Int Dent Res 2021;11(3):180-4. https://doi.org/10.5577/intdentres.2021.vol11.no3.7 Linguistic Revision: The English in this manuscript has been checked by at least two professional editors, both native speakers of English.